FDA site prioritization

www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ManualofPoliciesProcedures/UCM619302.pdf

The US Food and Drug Administration (FDA) has released an internal Manual of Policies and Procedures (MAPP) on how pharmaceutical manufacturing sites are prioritized and selected for surveillance inspections.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.